Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

The Second Pharma West Africa Conference
The Second Pharma West Africa Conference
Pharma West Africa To Explore Improving Access To Quality Medicines
EC authorises Celltrion’s Avtozma for multiple indications
EC authorises Celltrion’s Avtozma for multiple indications
Celltrion has secured marketing authorisation from the European Commission (EC) for Avtozma (CT-P47), a biosimilar to Chugai Pharmaceutical’s RoActemra (tocilizumab).
China Focus
China Focus
China Focus: Parkinson's possible to be blocked thanks to Chinese scientists' breakthrough research
Zealand Pharma steadfastly upholds amylin-based obesity drug strategy
Zealand Pharma steadfastly upholds amylin-based obesity drug strategy
The company has yet to secure a deal, after announcing plans to sign one with a big pharma company in August 2024. Nonetheless, CEO Adam Steensberg emphasised that Zealand is “exactly where it wants...
Boston Scientific announces pricing of €1.5 billion of senior notes
Boston Scientific announces pricing of €1.5 billion of senior notes
Boston Scientific Corporation Boston Scientific Corporation today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned finance subsidiary, has priced ...
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
IO Biotech Announces
IO Biotech Announces
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks
CSL Behring KK has gained approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) to manufacture and market subcutaneous (SC) injection 200mg Andembry (Garadacimab...
FDA Grants Fast Track Status to SIGX1094
FDA Grants Fast Track Status to SIGX1094
FDA Grants Fast Track Status to SIGX1094 for Diffuse Gastric Cancer
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Japanese researchers enhance mRNA
Japanese researchers enhance mRNA
Japanese researchers enhance mRNA cancer drugs' protein synthesis efficiency by 200 times
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand